SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma.
Follicular lymphoma (FL) is the second most common subtype of non-Hodgkin's lymphoma (NHL) in the Western world. FL constitutes the most frequent indolent lymphoma, well characterized by its clinical presentation related to nodal involvement and its morphologic and biologic features. It is often managed as an incurable disease. However, several active therapeutic approaches from the "wait and watch" strategy to the allogeneic transplantation are available for management of patients with FL and clearly have changed the natural history of this disease, achieving a long-term disease-free survival. Therapeutic decision is mostly conditioned by patient's characteristics, stage, histological grade, tumor burden, and risk-predicting factors. This article try to summarizes the diagnosis and treatment of this heterogeneous group of patients.
Rodríguez-Abreu
Delvys
D
Servicio de Oncología Médica, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Canarias, Spain. delvysra@yahoo.com
Llanos Muñoz
Marta
M
Provencio Pulla
Mariano
M
Rueda Domínguez
Antonio
A
Isla Casado
Dolores
D
D000465:Algorithms; D006801:Humans; D008224:Lymphoma, Follicular / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008495:Medical Oncology / Q000379:methods*; D012955:Societies, Medical; D013030:Spain